Have your own idea? Try our Stock Screener
Chinese (SSE) Biotech Industry Analysis
UpdatedApr 18, 2025
DataAggregated Company Financials
Companies72
- 7D-0.8%
- 3M4.5%
- 1Y-5.7%
- YTD4.1%
Last week, the Biotech industry hasn't moved much but Beijing Wantai Biological Pharmacy Enterprise is up 3.6% in that time. Unfortunately though, the industry is down 5.7% over the past 12 months. Earnings are forecast to grow by 44% annually.
Industry Valuation and Performance
Has the Chinese Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 18 Apr 2025 | CN¥835.9b | CN¥135.1b | CN¥11.7b | 31.2x | 71.4x | 6.2x |
| Sun, 16 Mar 2025 | CN¥867.5b | CN¥136.3b | CN¥11.6b | 32.4x | 75x | 6.4x |
| Tue, 11 Feb 2025 | CN¥837.2b | CN¥136.0b | CN¥10.8b | 34.5x | 77.8x | 6.2x |
| Thu, 09 Jan 2025 | CN¥795.5b | CN¥136.0b | CN¥10.8b | 32.8x | 73.9x | 5.8x |
| Sat, 07 Dec 2024 | CN¥902.9b | CN¥136.0b | CN¥10.8b | 34.5x | 83.9x | 6.6x |
| Mon, 04 Nov 2024 | CN¥898.8b | CN¥141.7b | CN¥11.2b | 36.8x | 80.2x | 6.3x |
| Wed, 02 Oct 2024 | CN¥966.1b | CN¥154.1b | CN¥14.5b | 39.2x | 66.9x | 6.3x |
| Fri, 30 Aug 2024 | CN¥777.3b | CN¥160.5b | CN¥16.7b | 29.8x | 46.4x | 4.8x |
| Sun, 28 Jul 2024 | CN¥800.0b | CN¥161.1b | CN¥17.3b | 30.1x | 46.2x | 5x |
| Tue, 25 Jun 2024 | CN¥835.1b | CN¥161.1b | CN¥17.3b | 31.4x | 48.3x | 5.2x |
| Thu, 23 May 2024 | CN¥941.1b | CN¥161.1b | CN¥17.3b | 38.7x | 54.5x | 5.8x |
| Sat, 20 Apr 2024 | CN¥914.4b | CN¥161.3b | CN¥20.3b | 35x | 45.1x | 5.7x |
| Mon, 18 Mar 2024 | CN¥1.0t | CN¥165.3b | CN¥21.9b | 38.3x | 47.1x | 6.2x |
| Wed, 14 Feb 2024 | CN¥955.7b | CN¥167.9b | CN¥21.4b | 31.9x | 44.6x | 5.7x |
| Fri, 12 Jan 2024 | CN¥1.1t | CN¥167.9b | CN¥21.4b | 38.8x | 49.5x | 6.3x |
| Sun, 10 Dec 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 39.7x | 52.3x | 6.7x |
| Tue, 07 Nov 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 40.7x | 51.7x | 6.6x |
| Thu, 05 Oct 2023 | CN¥1.1t | CN¥170.9b | CN¥25.2b | 42.6x | 41.7x | 6.2x |
| Sat, 02 Sep 2023 | CN¥1.0t | CN¥171.2b | CN¥25.3b | 38.5x | 40.1x | 5.9x |
| Mon, 31 Jul 2023 | CN¥1.1t | CN¥177.4b | CN¥29.9b | 40.4x | 37.5x | 6.3x |
| Wed, 28 Jun 2023 | CN¥1.1t | CN¥177.4b | CN¥29.3b | 37.7x | 36.3x | 6x |
| Fri, 26 May 2023 | CN¥1.2t | CN¥177.7b | CN¥29.6b | 43.9x | 39.1x | 6.5x |
| Sun, 23 Apr 2023 | CN¥1.2t | CN¥187.2b | CN¥36.5b | 40.2x | 33.9x | 6.6x |
| Tue, 21 Mar 2023 | CN¥1.2t | CN¥179.0b | CN¥35.8b | 43.7x | 34x | 6.8x |
| Thu, 16 Feb 2023 | CN¥1.3t | CN¥179.6b | CN¥37.9b | 42.5x | 34.5x | 7.3x |
| Sat, 14 Jan 2023 | CN¥1.3t | CN¥175.6b | CN¥37.9b | 41.9x | 34.3x | 7.4x |
| Mon, 12 Dec 2022 | CN¥1.3t | CN¥175.6b | CN¥37.9b | 38.9x | 33.5x | 7.2x |
| Wed, 09 Nov 2022 | CN¥1.3t | CN¥175.8b | CN¥38.0b | 39.3x | 33x | 7.1x |
| Fri, 07 Oct 2022 | CN¥1.1t | CN¥174.3b | CN¥40.2b | 30x | 28.1x | 6.5x |
| Sun, 04 Sep 2022 | CN¥1.3t | CN¥183.4b | CN¥39.8b | 34.6x | 31.4x | 6.8x |
| Tue, 02 Aug 2022 | CN¥1.3t | CN¥171.0b | CN¥43.5b | 34.3x | 28.8x | 7.3x |
| Thu, 30 Jun 2022 | CN¥1.3t | CN¥168.1b | CN¥42.4b | 39.3x | 31.3x | 7.9x |
| Sat, 28 May 2022 | CN¥1.2t | CN¥168.1b | CN¥42.4b | 34.5x | 27.7x | 7x |
| Mon, 25 Apr 2022 | CN¥1.2t | CN¥155.9b | CN¥41.3b | 37x | 30x | 7.9x |
Price to Earnings Ratio
30x
Current Industry PE
- Investors are optimistic on the Chinese Biotechs industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 71.4x which is higher than its 3-year average PE of 46.1x.
- The industry is trading close to its 3-year average PS ratio of 6.4x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have declined 34% per year over the last three years,
- Revenues have also declined 4.7% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | 0.93% | |
| Healthcare | 0.29% | |
| Biotech | -0.85% | |
| Biotech | -0.85% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 603392 Beijing Wantai Biological Pharmacy Enterprise | CN¥69.40 | 3.6% +CN¥3.0b | 3.2% | PE826.5x | |
| 002675 Yantai Dongcheng Pharmaceutical GroupLtd | CN¥14.80 | 16.3% +CN¥1.7b | 15.8% | PE66.4x | |
| 688136 Kexing Biopharm | CN¥35.55 | 31.5% +CN¥1.7b | 145.0% | PE225.4x | |
| 688382 InventisBio | CN¥20.43 | 7.4% +CN¥807.4m | 145.6% | PS69.7x | |
| 688105 Nanjing Vazyme Biotech | CN¥24.88 | 7.5% +CN¥680.6m | -0.08% | PS7.1x |